mdxhealth
Henry Le has extensive experience in clinical laboratory science, currently serving as a Clinical Laboratory Scientist at mdxhealth since February 2023. Prior roles include CLS II at Oncocyte Corporation from November 2021 to February 2023 and Clinical Laboratory Scientist positions at Pangea Laboratory and Color Genomics. Henry began a career in quality control as a QC Operation Trainer III at Natera, where employment lasted from June 2011 to November 2017. Educational qualifications include a Bachelor's degree obtained from the University of California, Davis between 2008 and 2010. Henry holds certification as a Clinical Genomics Molecular Biologist through the American Society for Clinical Pathology (CGMBS MB(ASCP)).
mdxhealth
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.